“The remaining proceeds from our recent financing further strengthened our balance sheet and our ability to execute the long-range plan we presented at our investor day held last month in New York ...

The Phase 3 EPIC trial is a randomized, sham-controlled, double-blind study evaluating NRTX-1001 cell therapy in adults with drug-resistant mesial temporal lobe epilepsy SAN FRANCISCO, Feb. 20, 2025 ...

The Supreme Court of the United States granted certiorari on January 17, 2025, in A.J.T. by and through A.T. v. Osseo Area Schools, Indep. Sch.

Children in England living with a rare and severe form of epilepsy could soon benefit from a new drug being rolled out on the ...

The talent of Wolfgang Amadeus Mozart, the famous Austrian composer, still captivates many audiences. Classical music lovers ...

Hundreds of children with a rare and severe form of epilepsy are hoping a new drug being rolled out on the NHS may provide a ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...

New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people in the United States ...

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.

Seizures in newborns are one of the most frequent acute neurological conditions among infants admitted to neonatal care units.

Seizures in newborns are one of the most frequent acute neurological conditions among infants admitted to neonatal care units. A study published in Developmental Medicine & Child Neurology indicates ...

A study published in Developmental Medicine & Child Neurology indicates that newborns experiencing neonatal seizures face an elevated risk of developing epilepsy.